DTC Ads To Be Studied By FDA With Eye On Efficacy Presentations
This article was originally published in The Pink Sheet Daily
Executive Summary
While mandated pie charts might be one result of the research, the agency’s study also could show drug marketers how to define and describe “high” and “low” efficacy.
You may also be interested in...
FDA’s Biggest DTC Advertising Study Eyes Online Promotion
The agency has 11 research projects under way, including a $2 million study of online Rx drug promotion; pharma spending on direct-to-consumer advertising declined in 2012 with biggest spends on Cymbalta and Cialis ads.
Census Delays Planned DDMAC Studies On Various Aspects Of DTC Advertising
FDA's ability to conduct studies of direct-to-consumer advertising is being impacted by the 2010 census, slowing two pending FDA studies just as the agency is preparing to start three more
Census Delays Planned DDMAC Studies On Various Aspects Of DTC Advertising
FDA's ability to conduct studies of direct-to-consumer advertising is being impacted by the 2010 census, slowing two pending FDA studies just as the agency is preparing to start three more